Require health plans, Medicaid to cover epinephrine and glucagon
Refer to Committee
Email me when HB 915 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 915. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill forces private health‑benefit plans and Ohio’s Medicaid program to pay for prescribed epinephrine and glucagon for children and teens when a doctor deems them medically necessary. It also limits any cost‑sharing to $60 per two‑injector package (or the equivalent dose for other forms), regardless of other deductibles or copays. Additional rules govern how Medicaid can apply cost‑sharing and how managed‑care plans may manage drug utilization.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 915
3 free questions a day, no accountHistory
- Referred to committee
- Introduced
Sponsors
- Phillip M. Robinson, Jr. · sponsor
- Anita Somani
- Beryl Piccolantonio
- C. Allison Russo
- Christine Cockley
- Desiree Tims
- Eric Synenberg
- Karen Brownlee
- Lauren McNally
- Meredith R. Lawson-Rowe
- Munira Abdullahi
- Rachel B. Baker
- Sean P. Brennan
- Terrence Upchurch
- Tristan Rader
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 915 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 915 freeOr ask your AI assistant about HB 915 directly:
Add to Claude, ChatGPT or Cursor